A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection-Reference-Cited by-同舟云学术

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

Published:2014-12 Issue:6 Volume:61 Page:1238-1246
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Muir Andrew J.,Arora Sanjeev,Everson Gregory,Flisiak Robert,George Jacob,Ghalib Reem,Gordon Stuart C.,Gray Todd,Greenbloom Susan,Hassanein Tarek,Hillson Jan,Horga Maria Arantxa,Jacobson Ira M.,Jeffers Lennox,Kowdley Kris V.,Lawitz Eric,Lueth Stefan,Rodriguez-Torres Maribel,Rustgi Vinod,Shemanski Lynn,Shiffman Mitchell L.,Srinivasan Subasree,Vargas Hugo E.,Vierling John M.,Xu Dong,Lopez-Talavera Juan C.,Zeuzem Stefan

Publisher

Elsevier BV

Subject

Hepatology

Reference43 articles.

1. Vertex Pharmaceuticals I. INCIVEK™ (telaprevir) Prescribing Information; 2012.

2. Merck Sharp & Dohme Corp. VICTRELISTM (boceprevir) [package insert]; 2013.

3. Janssen Therapeutics. OLYSIO™ (simeprevir) Prescribing Information; 2014.

4. Food and Drug Administration. SOVALDI™ (sofosbuvir) Prescribing Information; 2014.

5. Gaps in the achievement of effectiveness of HCV treatment in national VA practice;Kramer;J Hepatol,2012

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond;Seminars in Immunology;2024-03

2. Hepatitis D;JAMA;2023-12-26

3. Molecular analysis of the type III interferon complex and its applications in protein engineering;Biophysical Journal;2023-11

4. Type III interferon exerts thymic stromal lymphopoietin in mediating adaptive antiviral immune response;Frontiers in Immunology;2023-09-22

5. Interferon lambda restricts herpes simplex virus skin disease by suppressing neutrophil-mediated pathology;2023-09-14